TY - JOUR
T1 - Plasma polymerized silylated ciprofloxacin as an antibiotic coating
AU - Braceras, Inigo
AU - Azpiroz, Patxi
AU - Briz, Nerea
AU - Fratila, Raluca M.
AU - Oyarbide, Joseba
AU - Ipiñazar, Enrique
AU - Úlvarez, Noelia
AU - Atorrasagasti, Garbiñe
AU - Aizpurua, Jesus M.
PY - 2011/7/22
Y1 - 2011/7/22
N2 - Locally applied antibiotics under temporally controlled release present many advantages over systemic clinical treatments, e.g. efficiency and side effects. This can be achieved by a coating on top of the medical device, in which the antibiotic is stored. This study presents the use of plasma polymerization to produce such a coating using N,O-bis-tert- butyldimethylsilylated ciprofloxacin (silylciprofloxacin) as a precursor. Once exposed to physiological media, the outer layers of the coating release the antibiotic by a hydrolysis reaction. Thus, the plasma process parameters can control the speed of liberation through the coating polymerization. Besides, this study shows that the release products present antibiotic activity against a number of bacteria: E. coli, P. aeruginosa, and S. aureus. Ciprofloxacin release dynamics can be controlled by coating plasma polymerization parameters, allowing local controlled delivery of active antibiotic in physiologic conditions, and thus higher efficiency and lower side effects.
AB - Locally applied antibiotics under temporally controlled release present many advantages over systemic clinical treatments, e.g. efficiency and side effects. This can be achieved by a coating on top of the medical device, in which the antibiotic is stored. This study presents the use of plasma polymerization to produce such a coating using N,O-bis-tert- butyldimethylsilylated ciprofloxacin (silylciprofloxacin) as a precursor. Once exposed to physiological media, the outer layers of the coating release the antibiotic by a hydrolysis reaction. Thus, the plasma process parameters can control the speed of liberation through the coating polymerization. Besides, this study shows that the release products present antibiotic activity against a number of bacteria: E. coli, P. aeruginosa, and S. aureus. Ciprofloxacin release dynamics can be controlled by coating plasma polymerization parameters, allowing local controlled delivery of active antibiotic in physiologic conditions, and thus higher efficiency and lower side effects.
KW - antibacterial coatings
KW - drug release
KW - hydrolysis
KW - infection
KW - plasma polymerization
UR - http://www.scopus.com/inward/record.url?scp=79960221322&partnerID=8YFLogxK
U2 - 10.1002/ppap.201000160
DO - 10.1002/ppap.201000160
M3 - Article
AN - SCOPUS:79960221322
SN - 1612-8850
VL - 8
SP - 599
EP - 606
JO - Plasma Processes and Polymers
JF - Plasma Processes and Polymers
IS - 7
ER -